Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT01447602
Eligibility Criteria:
Inclusion Criteria:
* Males and females ages 12-19 years
* English speaking adolescent
* Parent may be monolingual or bilingual in Spanish
* DSM-IV diagnosis of MDD, dysthymia, DDNOS
* Moderate impairment in functioning
* Moderate to severe depression severity
* Expressed risk for suicide or reported non-medically lethal attempt. Non-lethal attempt is defined as an attempt that did not require medical hospitalization but may require psychiatric hospitalization which often includes being in the Emergency Room for several days because there was no bed available.
Exclusion Criteria:
* Suicide attempt in the past 4 months with medical lethality that requires hospitalization which often includes being in the ER for several days because there was no bed available.
* Severe impairment in functioning
* Diagnoses of Substance abuse, Schizophrenia, bipolar disorder,Conduct disorder, primary eating disorder, Psychosis, obsessive-compulsive disorder,
* Engagement in self-injurious that requires medical treatment in the past month
* Mental retardation or severe learning disability
* Medical illness that may interfere with treatment
* Current physical or sexual abuse
* Open Administration for Children's Services (ACS) case
* Pregnancy
* Already receiving treatment for depression or have begun a medication trial for another diagnosis within the previous three months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
19 Years
Study:
NCT01447602
Study Brief:
Protocol Section:
NCT01447602